Table 4.
Group | Num | INF-γ | IL-4 | IL-10 | IL-17 | IL-23 | TGF-βI |
---|---|---|---|---|---|---|---|
Control | 20 | 136.54±21.79 | 152.25±33.44 | 222.38±63.56 | 20.86±0.65 | 105.45±30.65 | 518.26±157.73 |
HPV | 20 | 126.80±17.58 | 176.31±23.66 | 216.39±49.80 | 21.11±0.55 | 112.09±26.32 | 539.08±126.36 |
CIN | 61 | 107.83±13.46a,b | 196.42±28.51a | 226.92±48.28a | 21.52±2.44 | 108.96±28.98 | 553.71±197.29 |
UCC | 38 | 88.25±12.37a,b,c | 204.38±16.90a | 261.53±31.80a,b,c | 22.78±1.92a,b,c | 148.91±30.97a,b,c | 636.54±108.45a,b |
Compared to the control group;
P<0.05.
Compared to the HPV group;
P<0.05.
Compared to the CIN group;
P<0.05.